Quantum Biopharma annual free cash flow
2020
2021
2022
2023
2024
Quantum Biopharma Free Cash Flow (FCF) History (QNTM)
Quantum Biopharma reported −$6.9M in free cash flow for fiscal 2024, an increase of $4.0M from the previous fiscal year.
View full Quantum Biopharma company overviewQuantum Biopharma free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2024 | 2024-12-31 | −$6.9M | $4.0M | — | — |
| 2023 | 2023-12-31 | −$10.8M | $17.6M | — | — |
| 2022 | 2022-12-31 | −$28.4M | −$7.7M | — | — |
| 2021 | 2021-12-31 | −$20.7M | −$1.6M | — | — |
| 2020 | 2020-12-31 | −$19.1M | — | — | — |
Quantum Biopharma quarterly free cash flow
No reported data
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Quantum Biopharma free cash flow growth trends
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Quantum Biopharma filings at SEC.gov ↗